Search Within

Kamal Nand Menghrajani

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (14)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (14)
  3. Department of Medicine (14)
  4. Epidemiology and Biostatistics (14)
  5. GSK Faculty (14)
  6. Hematologic Malignancies, Division of (14)

More Groups

People
  1. Ross Levine (11)
  2. Elli Papaemmanuil (10)
  3. Sean Devlin (10)
  4. Minal Patel (9)
  5. Yanming Zhang (8)
  6. Kelly Bolton (7)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2021 (1)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (2)
Publications
  1. Blood (7)
  2. American Journal of Hematology (1)
  3. Blood Advances (1)
  4. Haematologica (1)
  5. JCO Precision Oncology (1)
  6. Molecular Cell (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Nature Publishing Group (2)
  3. American Society of Clinical Oncology (1)
  4. Cell Press (1)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons, Inc. (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Bernard, E.; Nannya, Y.; Yoshizato, T.; Hasserjian, R. P.; Saiki, R.; Shiozawa, Y.; Devlin, S. M.; Tuechler, H.; Sarian, A.; Malcovati, L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save